Saratov JOURNAL of Medical and Scientific Research

Photodynamic therapy of psoriasis

Year: 2017, volume 13 Issue: №3 Pages: 678-681
Heading: Dermatovenerology Article type: Review
Authors: Utz S.R., Dobdina A.Ju., Talnikova Е.Е., Utz I.A.
Organization: Saratov State Medical University

The review presents literature data on the use of photodynamic therapy in the treatment of psoriasis. In addition, the article discloses aspects of the mechanism of action, indications and contraindications, as well as the development of possible side effects when using this phototherapeutic technique.

1. Tappeiner H. Ueber die Wirkung fluorescierende Stoffe auf Infusiorien nach Versuhen von Raab O. Munch Med Wochenschr 1900; 47: 5
2. Raab O. Ueber die Wirkung fluorescierende Stoffe auf Infusiorien. Z Biol 1900; 39: 524-546
3. Tappeiner H, Jesionek H. Therapeutische versuche mit fluoreszierenden stoffen. Munch Med Wochenschr 1903; 47: 2042-2044
4. Tappeiner, H, Jodlbauer A. Die sensibilisierende wirkung fluorescierender substanzen: Gesammelte untersuchungen uber die photodynamische erscheinung. F. О W 1907
5. Triesscheijna M, Baas PP, Schellensa J. Photodynamic therapy in oncology. Oncologist 2006; 11: 1034-1044
6. Hausmann W. Die sensibilisierende wirkung des ham-atoporphyrins. Biochem Z 1910; 30: 276-316
7. Hausmann W Die sensibilisierende Wrkung des Ham-atoporphyrins. Biochem Z 1911; 30: 276-316
8. Meyer-Betz F. Untersuchung uber die biologische (photodynamische) wirkung des hamatoporphyrins und anderer deri-vate des blutund gallenfarbstoffs. Dtsch Arch Klin Med 1913; 112: 476-503
9. Hamblin MR, Huang YY. Handbook of photomedicine. CRC Press 2014: 815
10. Wan MT, Lin JY Current evidence and applications of photodynamic therapy in dermatology. Clinical, Cosmetic and In-vestigational Dermatology 2014; 7: 145-163. 11. Choi YM, Adelzadeh L, Wu JJ. Photodynamic therapy for psoriasis. J Dermatolog Treat, Early Online: 1-6
12. Hong JS, Jung JY, Yoon JY, Suh DH. Acne treatment by methyl aminolevulinate photodynamic therapy with red light vs intense pulsed light. Int J Dermatol 2013; 52 (5): 614-619
13. Clark C, Bryden A, Dawe R, et al. Topical 5-amino-laevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoim-munol Photomed 2003; 19 (3): 134-41
14. Gholam P, Kroehl V, EnkAH. Dermatology life quality index and side effects after topical photodynamic therapy of actinic keratosis. Dermatology 2013; 226 (3): 253-259
15. Orenstein A, Kostenich G, Tsur H, et al. Temperature monitoring during photodynamic therapy of skin tumors with topical 5-ami-nolevulinic acid application. Cancer Lett 1995; 93 (2): 227-232
16. Carrion-Gutierrez M, Ramirez-Bosca A, Navarro-Lo-pez V, et al. Effects of Curcuma extract and visible light on adults with plaque psoriasis. Eur J Dermatol 2015; 25 (3): 240-6
17. Jin Y, Zhang X, Zhang B, et al. Nanostructures of an amphiphilic zinc phthalocyanine polymerconjugate for photodynamic therapy of psoriasis. Colloids and Surfaces B: Biointerfac-es2015; 128:405-409
18. Cunha JS, Amorese-O'Connell L, Gutierrez M, et al. Ultrasound imaging of nails in psoriasis and psoriatic arthritis. Curr Treat Options in Rheum 2017; 3: 129-140
19. Pradhan M, Singh D, Singh MR. Novel colloidal carriers for psoriasis: Current issues, mechanistic insight and novel delivery approaches. Journal of Controlled Release 2013; 170 (3): 380-395
20. MenterA, Gottlieb A, Feldman SR. Guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol 2008; 58 (5): 826-850
21. Stringer MR, Collins P, Robinson DJ. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Iwest Dermatol 1996; 107: 76-81
22. Silver H. Psoriasis vulgaris treated with haemotopor-phyrin. Arch Dermatol Syphilol 1937; 36: 1118-1119
23. Sharman WM, Allen CM, van Lier JE. Photodynamic therapeutics: basic principles and clinical applications. DDT 1999; 4 (11): 507-517
24. Richard EG, Hbnigsmann H. Phototherapy, psoriasis, and the age of biologies. Photodermatol, Photoimmunol & Pho-tomed 2014; 30(1): 3-7
25. Lee Y, Baron ED. Photodynamic therapy: current evidence and applications in dermatology. Semin Cutan Med Surg 2011; 30: 199-209
26. Collins P, Robinson DJ, Stringer MR, et al. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 137:743-9
27. Robinson DJ, Collins P, Stringer MR, et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Ve-nereol 1999;79:451-5
28. Beattie PE, Dawe RS, Ferguson J et al. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clin Exp Dermatol 2004; 29: 560-2
29. Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, et al. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol 2005; 152: 279-83
30. Smits T, Kleinpenning MM, van Erp PEJ, et al. A place-bocontrolled randomized study on the clinical effectiveness, im-munohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis. Br J Dermatol 2006; 155: 429-36
31. Kleinpenning MM, Kanis JH, Smits T, et al. The effects of keratolytic pretreatment prior to fluorescence diagnosis and photodynamic therapy with aminolevulinic acid-induced porphy-rins in psoriasis. J Dermatolog Treat 2010; 21: 245-51
32. Maytin EV, Honari G, Khachemoune A, et al. Vitamin D combined with aminolevulinate (ALA) — mediated photodynamic therapy (PDT) for human psoriasis: a proof-of-principle study. Isr JChem 2012; 52: 767-75
33. Bissonnette R, Tremblay JF, Juzenas P, et al. Systemic photodynamic therapy with aminolevulinic acid induced apopto-sis in lesional T-lymphocytes of psoriatic plaques. J Invest Dermatol 2002; 119:77-83.

2017_03-1_678-681.pdf392.64 KB

No votes yet